Breast specialist consultation
Detailed history, risk assessment, symptom review and clinical breast examination with a specialist.
A comprehensive, consultant-led breast screening pathway combining breast specialist consultation, clinical breast examination, mammography, breast and axilla ultrasound, 28+ biomarker blood panel, tumour markers and GP review in one structured package.
The Breast Cancer Alert Premium Plus Package is a comprehensive private breast screening pathway for women seeking rapid access, early detection and maximum reassurance. It combines specialist consultation and clinical breast examination, mammography, breast and axilla ultrasound, same-day blood collection with 28+ biomarkers, CA 15-3 and CEA tumour markers, and GP follow-up to explain results and advise on next steps. Package price: £1,295.
The package is designed to reduce fragmented care by combining specialist clinical review, complementary imaging and laboratory testing with GP-led interpretation.
Detailed history, risk assessment, symptom review and clinical breast examination with a specialist.
Breast X-ray imaging to assess calcifications, structural changes and suspicious breast abnormalities.
Ultrasound assessment of breast tissue and armpit lymph nodes to evaluate lumps, cysts and axillary findings.
28+ biomarker blood panel including tumour markers, followed by GP review and next-step planning.
A structured breast screening pathway combining specialist assessment, same-day imaging and extended laboratory testing.
The first visit includes a specialist consultation to understand your symptoms, background risk and the most appropriate same-day imaging pathway.
The GP follow-up brings imaging and blood results together so you receive clear explanation and practical guidance rather than fragmented reports.
Breast screening is stronger when the clinical assessment and imaging are interpreted together.
Helps detect calcifications, structural abnormalities and early cancer-related changes that may not be obvious on examination.
Assesses focal breast symptoms and helps differentiate cystic, solid and benign-appearing abnormalities.
Assesses armpit lymph nodes and axillary findings, which are important in a complete breast pathway.
The blood panel provides broader health insight, but it does not replace imaging or specialist assessment.
CA 15-3 is a breast tumour marker that may be raised in malignant or benign conditions. It is supportive only and must be interpreted in clinical context.
CEA is a general tumour marker associated with several conditions and may also rise with inflammation, smoking or non-cancer causes.
Designed for women who want a more complete private breast pathway with rapid access and structured follow-up.
For women with breast lumps, pain, nipple discharge, skin changes, asymmetry or focal concern.
For patients with a family history of breast cancer who want a deeper private assessment.
For women over 40 seeking private breast screening with mammography and ultrasound.
For patients who prefer specialist review, dual imaging and extended blood testing in one pathway.
For time-poor patients wanting rapid private access and structured reporting.
For visitors to London who need a coordinated breast screening pathway and clear written results.
The package is designed to reduce uncertainty and avoid fragmented appointments.
Breast specialist consultation, clinical examination, mammography, breast and axilla ultrasound and blood collection are completed through one coordinated pathway.
Imaging reports are provided promptly to support fast clinical review and reduce waiting.
Blood test results usually become available following same-day collection.
GP review is provided in person or virtually to explain the full clinical picture and advise on any referral or follow-up needed.
All-inclusive private breast screening package price with no hidden costs.
Breast specialist consultation, mammography, breast and axilla ultrasound, 28+ biomarker blood panel, GP review and written reporting.
Breast specialist consultation, clinical breast examination and GP consultation for results explanation and planning.
Mammography, breast and axilla ultrasound, blood collection, 28+ biomarkers, CA 15-3 and CEA.
This is a private breast screening pathway. It is not an emergency service and does not replace urgent assessment if symptoms are rapidly worsening, infection is suspected, there is severe pain, heavy bleeding, acute illness or any urgent medical concern.
Tumour markers such as CA 15-3 and CEA are not diagnostic on their own. They may be normal in cancer or raised for non-cancer reasons. They should only be interpreted alongside specialist assessment, mammography, ultrasound and clinical context.
London Private Ultrasound supports local, national and international patients seeking premium private breast screening.
27 Welbeck Street, London W1G 8EN
Harley Street medical district, close to Marylebone, Oxford Circus, Bond Street and Mayfair.
54–56 Victoria Street, St Albans AL1 3HZ
Convenient for patients across St Albans, Hertfordshire and surrounding areas.
A professional private breast pathway supported by breast specialist assessment, ultrasound expertise, GP review, clinical governance and prescribing/medication input where relevant.
Provides medical governance and GP-led result interpretation for health screening pathways.
Supports regulated care, patient safety, clinic governance and operational standards.
Supports patient information, medical content governance and diagnostic service development.
Experienced ultrasound consultant supporting diagnostic imaging and scan reporting.
Supports medication review and prescribing input where relevant to screening pathways.
The package includes breast specialist consultation, clinical breast examination, mammography, breast and axilla ultrasound, 28+ biomarker blood panel, CA 15-3 and CEA tumour markers, GP consultation, written reports and follow-up planning.
The Breast Cancer Alert Premium Plus Package is listed at £1,295.
Yes. The page is designed as a same-day pathway for specialist consultation, clinical examination, imaging and blood collection.
Imaging reports are usually available within 24 hours, and blood results usually within 1–3 days.
No GP referral is required. You can book privately with London Private Ultrasound.
Tumour markers such as CA 15-3 and CEA are supportive tests only. They are not definitive cancer tests and must be interpreted alongside imaging and clinical assessment.
Yes. Mammography is included alongside breast and axilla ultrasound as part of a more complete breast imaging pathway.
The package is suitable for women with breast symptoms such as lumps, pain, nipple discharge or skin changes, but urgent or rapidly worsening symptoms should be assessed promptly through appropriate medical pathways.
Take a proactive approach to breast health with specialist assessment, same-day imaging, extended biomarkers and structured GP follow-up.
Clinical review and medical oversight by the London Private Ultrasound clinical team. Content reviewed June 2026. This page is patient information and does not replace urgent medical assessment when symptoms are acute or concerning.
London Private Ultrasound
Typically replies within minutes
Any questions related to Making an Appointment?
🟢 Online | Privacy policy
WhatsApp us